510(k) Report

510(k) · Cleared

Cleared

BD Texium™ Closed Male Luer

K223076510(k) TraditionalCleared Mar 24, 2023175-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Care Fusion · ONB Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System

Cleared on Mar 24, 2023 as substantially equivalent to K053049 (Cardinal Health, Alaris Products, 2006) after a 175-day review. Its family tree reaches back 3 generations to 1988. 1 later device descends from it.

Decided
Mar 24, 2023
Review
175 days
Class
Class II
Product code
ONB
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K883614 (1988). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor1997: 1 other ancestor1995: 1 other ancestor1994: 1 other ancestor2023: 1 descendant clearedK883614 · Cytoguard (R) · Survival Technology, Inc. · 1988K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K053049 · Alaris Safety Male Luer · Cardinal Health, Alaris Products · 2006 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor3 generations back: 3 other ancestors 1 generation forward: 1 descendant K053049 · Alaris Safety Male Luer · Cardinal Health, Alaris Products · 2006 · recalledK972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880
  1. Root · 3 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 2 generations backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. 1 generation backK053049 Alaris Safety Male LuerCardinal Health, Alaris Products · 2006 · Recalled
  4. This deviceK223076 BD Texium™ Closed Male LuerCare Fusion · 2023
  5. Descendant · cites it directly · 0 of its ownK231888 BD Texium™ Needle-Free SyringeCare Fusion · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K231888BD Texium™ Needle-Free SyringeCare Fusion · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K883614Cytoguard (R)Survival Technology, Inc.1988—
−2K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
−1K053049Alaris Safety Male LuerCardinal Health, Alaris Products20063
0 (this device)K223076BD Texium™ Closed Male LuerCare Fusion2023—
+1K231888BD Texium™ Needle-Free SyringeCare Fusion2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510
199710
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K223076, 1988–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ONB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new ONB device

  1. #1 K240171 ProSeal™ Injector Plus (Model no. 421050)score 18.2 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053049Alaris Safety Male Luer
Summary page 4
…Class II Product Code: FPA Classification Panel: General Hospital Premarket Notification: K053049 Reason for the Submission The reason for this submission is to incorporate the following changes: • New sterilization cl…
Cardinal Health, Alaris Products20063

Also cleared against K053049: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231888BD Texium™ Needle-Free SyringeCare Fusion20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 35 years and passes through 4 companies; a new generation was cleared every 9.0 years on median.
  • 3 of the 7 ancestors have a recall of any class.
  • Of its descendants, K231888 (Care Fusion, 2023) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K053049.

How does its category compare?

All ONB devices

ONB Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · ONB

6in 2025

2013: 32014: 22015: 32017: 22018: 62019: 12020: 32021: 32022: 12023: 32024: 82025: 6
2007high 8 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ONB

60in 2025

2013: 58 days median2015: 235 days median2018: 249 days median2020: 213 days median2021: 277 days median2023: 175 days median2024: 102 days median2025: 60 days median
2007high 277 (2021) · low 58 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · ONB

38in 2025

2016: 12019: 1, 1 Class I2020: 42022: 12023: 12024: 12025: 382026 (partial year): 3
2007high 38 (2025) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · ONB

934in 2025

2012: 12013: 22014: 32015: 42016: 132017: 662018: 2282019: 4642020: 4422021: 5482022: 4482023: 4562024: 6862025: 934
2007high 934 (2025) · low 0 (2007)2025

MAUDE reports naming product code ONB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—01
201335802
20142—03
2015323504
20160—113
20172—066
201862490228
20191—1 (1)464
202032134442
202132770548
20221—1448
202331751456
202481021686
202566038934
20260—3—

What is it indicated for?

The BD Texium™ Closed Male Luer (CML) is a sterile, single-use closed system drug transfer device (CSTD) intended for the reconstitution, transfer and administration of hazardous and non-hazardous drugs when paired with the SmartSite™ NFC.

The BD Texium™ Closed Male Luer (CML) is indicated for use by trained healthcare professionals within healthcare facilities who prepare and/or administer non-hazardous and hazardous drugs for adults, pediatrics and neonates.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223076: BD Texium™ Closed Male Luer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K223076

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026